Videos
My bookmarks
My bookmarks

Enhanced Liver Fibrosis (ELF™) Test

The only blood test endorsed by international guidelines for the diagnostic and prognostic assessment of liver fibrosis due to NASH, a highly prevalent yet significantly underdiagnosed disease.*


Please complete this form to receive the following information by email.


ELF Brochure (US)

The ELF Test web page

*In the U.S. the ELF Test is not for use in the diagnosis of NASH or for the staging of fibrosis. The ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.

You are entering a global domain of Siemens Healthineers.

If you choose to continue, please note that information in this domain is meant to be generic and country-independent. The devices displayed or mentioned may not be commercially available in all countries and their future availability cannot be guaranteed.

Continue

All EventsVideosShape SpotlightCorporate websiteHealthcare professionalsFAQSubscribe to our newsletterJobs & Careers